Trans American Aquaculture (GRPS) Return on Assets (2024 - 2025)
Trans American Aquaculture (GRPS) reported Return on Assets of 0.02% for Q3 2025, down 2.0% on a YoY basis from 0.02% in Q3 2024, and up 20.32% quarter-over-quarter from 0.02% in Q2 2025.
Trans American Aquaculture (GRPS) Return on Assets (2024 - 2025) Analysis & Trends
Trans American Aquaculture has reported Return on Assets for 2 years, with the latest figure at 0.02% in Q3 2025.
- For the quarter ending Q3 2025, Return on Assets fell 2.0% year-over-year to 0.02%; the trailing twelve-month figure through Sep 2025 stood at 0.02% (down 2.0% YoY), and the FY2024 full-year result was 0.01%, changed 0.0% from the prior year.
- Return on Assets for Q3 2025 stood at 0.02%, up from 0.02% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q3 2024, with the low at 0.03% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.00% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.00% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.00% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 0.00% |
| 10 | Trans American Aquaculture | - | - | - | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |